Angiography is the gold standard and objective evidence of myocardial ischemia is mandatory if lesion severity is questionable - indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (PRO) -

Circulation Journal

Volumn 75, Issue 1, 2011, Pages 204-210

  Nakamura, Masato ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioplasty; Coronary artery disease; Ischemia; Percutaneous coronary intervention (PCI); Perfusion

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FRACTIONAL FLOW RESERVE; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; NON INVASIVE MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MYOCARDIAL ISCHEMIA; OBSERVER VARIATION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 78651258859     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0881     Document Type: Article

References (39)

1. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet 2003; 361: 847-858.
2. Moses JW, Stone GW, Nikolsky E, Mintz G, Dangas G, Grube E, et al. Drug-eluting stent in the treatment of intermediate lesions; pooled analysis from four randomized trials. J Am Coll Cardiol 2006; 47: 2164-2171.
3. Amemiya S, Takao H, Computed tomographic coronary angiography for diagnosis stable coronary artery disease: A cost-utility and cost-effectiveness analysis. Circ J 2009; 73: 1263-1270.
4. Matsumoto N, Nagao K, Hirayama A, Sato Y. Non-invasive assessment and clinical strategy of stable coronary artery disease by magnetic resonance imaging, multislice computed tomography and myocardial perfusion SPECT. Circ J 2010; 74: 34-40.
5. Topol EJ, Nissen SE. Our preoccupation with luminology: The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995; 92: 2333-2342.
6. Tobis JM. Intravascular ultrasound: A fantastic voyage. Circulation 1990; 81: 2190-2192.
7. Yamagishi M, Hosokawa H, Saito S, Kanemitsu S, Chino M, Koyanagi S, et al. Coronary disease morphology and distribution determined by quantitative angiography and intravascular ultrasound. Circ J 2002; 66: 735-740.
8. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, et al. Limitation of angiography in the assessment of plaque distribution in coronary artery disease: A systemic study of target lesion eccentricity in 1446 lesions. Circulation 1996; 93: 924-931.
9. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995; 92: 39-46.
10. Pijls NH, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, et al. Fractional flow reserve: A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92: 3183-3193.
11. Fischer JJ, Samady H, McPherson JA, Sarembock IJ, Powers ER, Gimple LW, et al. Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity. Am J Cardiol 2002; 90: 210-215.
12. Pijls NH, Van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van'tVeer M, et al. Percutaneous coronary intervention of fractionally nonsignificant stenosis: 5-year follow up of DEFER study. J Am Coll Cardiol 2007; 49: 2105-2111.
13. Tonino PA, De Bruyne B, Pijils NH, Siebert U, Ikeno F, van't Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 15: 213-224.
14. Tanaka S, Noda T, Segawa T, Minagawa T, Watanabe S, Minatoguchi S. Relationship between functional exercise capacity and functional stenosis in patients with stable angina and intermediate coronary stenosis. Circ J 2009; 73: 2308-2314.
15. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 2008; 300: 1765-1773.
16. Fox KA. COURAGE to change practice? Revascularization in patients with stable coronary artery disease. Heart 2009; 95: 689-692.
17. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR, Chaitman BR, et al. Long-term survival of medically treated patients in the coronary artery bypass surgery study (CASS) registry. Circulation 1994; 90: 2645-2657.
18. Califf RM, Armstrong PW, Carver JR, D'Agostino RB, Strauss WE. 27th Bethesda conference; matching the intensity of risk factor management with the hazard for coronary disease events: Task force 5: Stratification of patients into high, medium and low risk subgroups for purpose of risk factor management. J Am Coll Cardiol 1996; 27: 1007-1019.
19. Gould KL, Lipscomb K, Hmilton GW. Physiologic basis for assessing critical coronary stenosis: Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974; 33: 87-94.
20. DeRouen TA, Murray JA, Owen W. Variability in the analysis of coronary angiograms. Circulation 1977; 55: 324-328.
21. Goldberg RK, Kleiman NS, Minor ST, Abukhalil J, Raizner AE. Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA. Am Heart J 1990; 119: 178-184.
22. Bech GL, De Bruyne B, Pijls NH, Muinck ED, Hoormtje JCA, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial. Circulation 2001; 103: 2928-2934.
23. Lauchance P, Dery JP, Rodes-Cabau J, Potvin JM, Barbeau G, Bertrand OF, et al. Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with non-invasive stress tests prior to cardiac catheterization. Cardiovasc Revasc Med 2008; 9: 229-234.
24. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med 1996; 334: 1703-1708.
25. Japanese Circulation Society. Guidelines for clinical use of cardiac nuclear medicine (JCS 2005). Circ J 2005; 69(Suppl 4): 1125-1202.
26. Qiao HJ, Fishbein MC. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cardiol 1991; 17: 1138-1142.
27. Fleischmann KE, Hunking MG. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic tests performance. JAMA 1998; 280: 913-920.
28. Yanagisawa H, Chikamori T, Tanaka N, Usui Y, Takazawa K, Yamashina A. Application of pressure-derived myocardial fractional flow reserve in assessing the functional severity of coronary artery stenosis in patients with diabetes mellitus. Circ J 2004; 68: 993-998.
29. Tanaka N, Takazawa K, Takeda K, Aikawa M, Shindo N, Amaya K, et al. Coronary flow-pressure relationship distal to epicardial stenosis. Circ J 2003; 67: 525-529.
30. Courtis J, Rodes-Cabau, Larosa E, Dery JP, Nguyen CM, Proulx G, et al. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Cathet Cardiovasc Diagn 2008; 71: 541-548.
31. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaji A, Fermandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-1660.
32. Van de Werf, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients with persistent ST-segment elevation: The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of cardiology. Eur Heart J 2008; 29: 2909-2945.
33. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
34. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, Mac-Gregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515.
35. Califf RM, Phillips HR, Hindman MC, Mark DB, Lee KL, Behar VS, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985; 5: 1055-1063.
36. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
37. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-1291.
38. Akasaka T. What can we expect in PCI in patients with chronic coronary artery disease: Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Con). Circ J 2011; 75: 211-217.
39. Werner GS, Surber R, Ferrari M, Fritzenwanger M, Figulla HR. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J 2006; 27: 2406-2412.